AI is transforming the pharmaceutical industry, particularly in drug discovery and clinical trials. However, this transformation brings significant legal risks, including product liability and data privacy concerns. A recent study indicates that 75% of pharmaceutical leaders prioritize AI governance at the executive level.
To address these challenges, a three-tiered governance framework is proposed, involving an AI standing committee, a C-suite AI committee, and board oversight. This structure aims to ensure comprehensive oversight and risk management in AI-enabled clinical development. Implementing such a framework is essential for navigating the complex legal landscape surrounding AI in pharmaceuticals.
• 75% of pharma leaders prioritize AI governance at the executive level.
• A three-tiered governance framework is essential for AI risk management.
AI governance is crucial for managing legal risks associated with AI in pharmaceuticals.
This committee serves as the first line of defense in overseeing AI-enabled clinical development.
This committee analyzes reports from the standing committee and advises the CEO on AI-related decisions.
CVS Health is involved in discussions about AI's impact on drug development and patient care.
Bain's study highlights the importance of AI governance in the pharmaceutical sector.
Winston & Strawn's attorneys provide guidance on managing legal risks associated with AI in pharmaceuticals.
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.